Cited by

• Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

  Currim F, Tanwar R, Brown-Leung JM, Paranjape N, Liu J, Sanders LH, Doorn JA, Cannon JR. Currim F, et al. Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2. Neurotoxicology. 2024. PMID: 38964509 Free PMC article. Review.
• Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

  Lawana V, Um SY, Rochet JC, Turesky RJ, Shannahan JH, Cannon JR. Lawana V, et al. Toxicol Sci. 2020 Jan 1;173(1):171-188. doi: 10.1093/toxsci/kfz210. Toxicol Sci. 2020. PMID: 31562763 Free PMC article.
• Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits.

  Laguna A, Peñuelas N, Gonzalez-Sepulveda M, Nicolau A, Arthaud S, Guillard-Sirieix C, Lorente-Picón M, Compte J, Miquel-Rio L, Xicoy H, Liu J, Parent A, Cuadros T, Romero-Giménez J, Pujol G, Giménez-Llort L, Fort P, Bortolozzi A, Carballo-Carbajal I, Vila M. Laguna A, et al. Nat Commun. 2024 Oct 11;15(1):8819. doi: 10.1038/s41467-024-53168-7. Nat Commun. 2024. PMID: 39394193 Free PMC article.
• Melanin affinity and its possible role in neurodegeneration.

  Karlsson O, Lindquist NG. Karlsson O, et al. J Neural Transm (Vienna). 2013 Dec;120(12):1623-30. doi: 10.1007/s00702-013-1062-5. Epub 2013 Jul 3. J Neural Transm (Vienna). 2013. PMID: 23821370 Review.
• The Oxidative Pathway to Dopamine-Protein Conjugates and Their Pro-Oxidant Activities: Implications for the Neurodegeneration of Parkinson's Disease.

  Wakamatsu K, Nakao K, Tanaka H, Kitahori Y, Tanaka Y, Ojika M, Ito S. Wakamatsu K, et al. Int J Mol Sci. 2019 May 25;20(10):2575. doi: 10.3390/ijms20102575. Int J Mol Sci. 2019. PMID: 31130632 Free PMC article.